semaglutide compound news Some people are overdosing on semaglutide, FDA warns | What you should know Drugmakers battle pharmacies over compounded

More must be done to ensure that everyone has access to safe, effective treatment, regardless of their location

de Graaf C, Blom WA, Smeets PA, Stafleu A, Hendriks HF

Symptoms may include burning in the chest after eating, pain that worsens when lying down, or a bitter or acidic taste in the mouth

They reduce insulin resistance

Disclosure This article has been written independently and reflects solely the opinion of the authors without any potential conflict of interest

Pipeline (Phase 3 trials completed, FDA decision pending as of April 2026): Survodutide (BI 456906): Dual GLP-1/glucagon agonist from Boehringer Ingelheim